Henry Schein Inc (FRA:HS2)
€ 68.18 -0.3 (-0.44%) Market Cap: 8.79 Bil Enterprise Value: 11.14 Bil PE Ratio: 25.03 PB Ratio: 2.65 GF Score: 86/100

Henry Schein Inc at JPMorgan Healthcare Conference Transcript

Jan 15, 2020 / 07:00PM GMT
Release Date Price: €61.98 (+4.75%)
Michael Roman Minchak
JP Morgan Chase & Co, Research Division - Analyst

Good morning, everyone, and welcome. We're very pleased to have Henry Schein presenting today at the conference. My name is Michael Minchak, and I'm a member of the health care services equity research team here.

For those of you who may not know, Henry Schein is one of the leading distributors in the dental and the medical products area as well as with technology and value-added services. So today, with us, we have CEO, Stanley Bergman; and CFO, Steve Paladino, to tell us more about the story. We're going to do a little bit of a different format here today with a fireside chat. And following the session, we'll have breakout questions in -- across the hall in the Georgian Room.

But before we begin with that, I'm going to hand it over to Stanley to make some introductory comments, and then we'll get into the Q&A.

Stanley M. Bergman
Henry Schein, Inc. - Executive Chairman & CEO

Thank you, Mike. Thank you all for being here. I'll be very brief because I'd

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot